Search research articles
Contact Us
Filters
Showing results (51-60 of 217) with videos related to
Page
of 22
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 12, 2025
Assessing the Status of Cyclin E1 (CCNE1) From Gene to Protein Level in Ovarian and Endometrial Carcinomas: A Systematic Review
Alexis Trecourt, Catherine Genestie, Alexander Valent, et al.
Bulletin Du Cancer
|
October 11, 2021
[Surgical de-escalation in gynecologic oncology]
François Zaccarini, Claire Sanson, Amandine Maulard, et al.
JNCI Cancer Spectrum
|
June 30, 2020
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)
Olivier Colomban, Michel Tod, Julien Peron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 15, 2025
Prognosis of stage I ovarian mucinous tumors according to expansile and infiltrative types
Malek Bouhani, Stéphanie Schérier, Catherine Genestie, et al.
Bulletin Du Cancer
|
September 22, 2020
[Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer]
Jérôme Alexandre, Marie Aude Le Frere-Belda, Karine Prulhiere, et al.
Gynecologic Oncology
|
November 14, 2013
Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants
Alexandra Leary, Marie Christina Petrella, Patricia Pautier, et al.
The American Journal of Surgical Pathology
|
August 2, 2024
Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)
Joanna Cyrta, Riwan Brillet, Enora Laas, et al.
Investigational New Drugs
|
December 15, 2018
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer
Alexandra Leary, Christophe Le Tourneau, Andrea Varga, et al.
Cancer Chemotherapy and Pharmacology
|
December 24, 2008
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy
Alexandra Leary, L Assersohn, D Cunningham, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 22, 2018
Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type
Sebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Page
of 22
Search research articles
Search
Showing results (51-60 of 217) with videos related to
Sort By:
Page
of 22
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 12, 2025
Assessing the Status of Cyclin E1 (CCNE1) From Gene to Protein Level in Ovarian and Endometrial Carcinomas: A Systematic Review
Alexis Trecourt, Catherine Genestie, Alexander Valent, et al.
Bulletin Du Cancer
|
October 11, 2021
[Surgical de-escalation in gynecologic oncology]
François Zaccarini, Claire Sanson, Amandine Maulard, et al.
JNCI Cancer Spectrum
|
June 30, 2020
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)
Olivier Colomban, Michel Tod, Julien Peron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 15, 2025
Prognosis of stage I ovarian mucinous tumors according to expansile and infiltrative types
Malek Bouhani, Stéphanie Schérier, Catherine Genestie, et al.
Bulletin Du Cancer
|
September 22, 2020
[Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer]
Jérôme Alexandre, Marie Aude Le Frere-Belda, Karine Prulhiere, et al.
Gynecologic Oncology
|
November 14, 2013
Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants
Alexandra Leary, Marie Christina Petrella, Patricia Pautier, et al.
The American Journal of Surgical Pathology
|
August 2, 2024
Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)
Joanna Cyrta, Riwan Brillet, Enora Laas, et al.
Investigational New Drugs
|
December 15, 2018
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer
Alexandra Leary, Christophe Le Tourneau, Andrea Varga, et al.
Cancer Chemotherapy and Pharmacology
|
December 24, 2008
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy
Alexandra Leary, L Assersohn, D Cunningham, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 22, 2018
Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type
Sebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Page
of 22